FindTrial
Sign In

Effect of Oral Pregabalin on efficacy of 4% Articaine used as IANB with Buccal infiltration and 4% Articaine used as Buccal and Lingual Infiltration in Mandibular molars with symptomatic irreversible pulpitis.

Comparative Evaluation of effect of Oral Premedication with Pregabalin on efficacy of 4% Articaine used as IANB with Buccal infiltration and 4% Articaine used as Buccal and Lingual Infiltration in Mandibular molars with Symptomatic Irreversible Pulpitis- A prospective randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054078
Enrollment
150
Registered
2023-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R52- Pain, unspecified

Interventions

None listed

Sponsors

SGT UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: There should be active pain in mandibular first and second molars without any periapical radiolucency. Patients with no history of trauma to involved tooth. Patients with vital coronal pulp.

Exclusion criteria

Exclusion criteria: Patients with periapical pathology. Retreatment cases. Cases with non vital pulp. Pregnancy or lactating patients. Diabetic patients. Those with allergy to LA or sulphur drugs. Patients under neurologic or psychiatric treatment

Design outcomes

Secondary

MeasureTime frame
Evaluation of effectiveness of local anesthesiaTimepoint: 60minutes,65minutes,70minutes,75minutes—

Primary

MeasureTime frame
Evaluation of painTimepoint: 75minutes,90minutes—

Countries

India

Contacts

Public ContactDR MANDEEP S GREWAL

SGT UNIVERSITY

drmandeepsgrewal@yahoo.co.in9810805880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026